Cellectar Biosciences CEO James Caruso's 2020 pay rises 9% to $1M
Cellectar Biosciences reports 2020 executive compensation
By ExecPay News
Published: May 13, 2021
Cellectar Biosciences reported fiscal year 2020 executive compensation information on May 13, 2021.
In 2020, five executives at Cellectar Biosciences received on average a compensation package of $607K, a 49% increase compared to previous year.
Average pay of disclosed executives at Cellectar Biosciences
James V. Caruso, Chief Executive Officer, received $1M in total, which increased by 9% compared to 2019. 47% of Caruso's compensation, or $475K, was in salary. Caruso also received $333K in bonus and $209K in option awards.
Igor Grachev, Chief Medical Officer, received a compensation package of $584K. 41% of the compensation package, or $239K, was in other compensation.
Jarrod Longcor, Chief Business Officer, earned $575K in 2020, a 7% increase compared to previous year.
Dov Elefant, Chief Financial Officer, received $472K in 2020, which increases by 51% compared to 2019.
John E. Friend II, Chief Medical Officer, earned $386K in 2020.
Related executives
You may also like
Source: SEC filing on May 13, 2021.